Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics

John J Cush, Kathryn H. Dao (Autoren)

Buch | Hardcover

240 Seiten

2012
W B Saunders Co Ltd (Verlag)
978-1-4557-5065-8 (ISBN)

Artikel merken

Addresses one of the most significant issues facing the rheumatologist today - drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon.

Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today--drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.

Reihe/Serie	The Clinics: Internal Medicine
Verlagsort	London
Sprache	englisch
Maße	152 x 229 mm
Gewicht	460 g
Themenwelt	Medizinische Fachgebiete ► Innere Medizin ► Rheumatologie
ISBN-10	1-4557-5065-4 / 1455750654
ISBN-13	978-1-4557-5065-8 / 9781455750658
Zustand	Neuware